<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We identified a novel human long <z:chebi fb="0" ids="37554">fatty acyl CoA</z:chebi> synthetase 2 gene, ACS2, as a new ETV6 fusion partner gene in a recurrent t(5;12)(q31;p13) translocation in a patient with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) with basophilia, a patient with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) with <z:hpo ids='HP_0001880'>eosinophilia</z:hpo>, and a patient with <z:hpo ids='HP_0011009'>acute</z:hpo> eosinophilic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (AEL) </plain></SENT>
<SENT sid="1" pm="."><plain>ACS2 is expressed in the brain and bone marrow and is highly conserved in man and rats </plain></SENT>
<SENT sid="2" pm="."><plain>The resulting ETV6/ACS2 fusion transcripts showed an out-frame fusion of exon 1 of ETV6 to exon 1 of ACS2 in the AEL case, an out-frame fusion of exon 1 of ETV6 to exon 11 of ACS2 in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> case, and a short in-frame fusion of ETV6 exon 1 to the 3' untranslated region of ACS2 in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> case </plain></SENT>
<SENT sid="3" pm="."><plain>Reciprocal ACS2/ETV6 transcripts were identified in two of the cases </plain></SENT>
<SENT sid="4" pm="."><plain>Fluorescence in situ hybridization (FISH) analysis with ETV6 cosmids on 12p13, and BACs and P1s on 5q31, demonstrated that the 5q31 breakpoints of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and AEL cases involved the 5' portion of the ACS2 gene, and that the 5q31, breakpoint of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> case involved the 3' portion of the ACS2 gene </plain></SENT>
<SENT sid="5" pm="."><plain>None of the resulting chimeric transcripts except for the ACS2/ETV6 transcript in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> case led to a fusion protein </plain></SENT>
<SENT sid="6" pm="."><plain>Disruption of the second ETV6 allele by t(12;19) was detected in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> case by FISH analysis </plain></SENT>
<SENT sid="7" pm="."><plain>These observations suggest that the disruption of ETV6 and/or ACS2 may lead to the pathogenesis of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> with t(5;12)(q31;p13) </plain></SENT>
</text></document>